UNITY BIOTECHNOLOGY INC - COM (UBX)

CUSIP: 91381U101

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class
Equity / COM
Total 13F shares
12,748,096
Share change
-52,044
Total reported value
$204,370,317
Price per share
$16.29
Number of holders
42
Value change
-$274,323
Number of buys
27
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 91381U101?
CUSIP 91381U101 identifies UBX - UNITY BIOTECHNOLOGY INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of UNITY BIOTECHNOLOGY INC - COM (UBX) as of Q3 2018

As of 30 Sep 2018, UNITY BIOTECHNOLOGY INC - COM (UBX) was held by 42 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,748,096 shares. The largest 10 holders included BAILLIE GIFFORD & CO, FMR LLC, Capital World Investors, EcoR1 Capital, LLC, Partner Fund Management, L.P., NF Trinity Capital (Hong Kong) Ltd, GOLDMAN SACHS GROUP INC, BlackRock Inc., Partner Investment Management, L.P., and Vanguard Group Inc. This page lists 42 institutional shareholders reporting positions in this security for the Q3 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.